| 标题 |
PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Prostate 作者:Daniel P. Petrylak; Nicholas J. Vogelzang; Kamal Chatta; Mark T. Fleming; David C. Smith; et al 出版日期:2019-11-19 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)